Wegovy

Last Reviewed: Oct 29, 2024

Drug Details


Generic Name:

Semaglutide injection

Common Brands:

Wegovy, Ozempic, Rybelsus

Availability:

Prescription only

Therapeutic Class:

GLP-1 receptor agonist

Forms:

Injection solution in a prefilled single-use pen

Administration:

Subcutaneous injection

Therapeutic Uses:

  • To help with chronic weight management in obese or overweight American adults and children above 12 years of age
  • To lower the risk of major cardiovascular events like stroke, heart attack, and death in overweight or obese adults with blood vessel or heart disease

Controlled Status:

Not a controlled substance


Wegovy Drug Class

Wegovy (wee-go-vee) is a glucagon-like-peptide-1 (GLP-1) receptor agonist.

Wegovy Age Range

Wegovy is approved for use in:

  • Adults with a body mass index (BMI) of 30 kg/m2 or higher or a BMI of 27 kg/m2 or higher and at least one of the serious health issues related to obesity, such as high blood pressure, type 2 diabetes, or high cholesterol. 
  • Children 12 years of age and older with a BMI at the 95th percentile or higher.